If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuantum Data Regulatory News (MAST)

  • There is currently no data for MAST

Business Update

13 Jun 2024 07:00

RNS Number : 2136S
Mast Energy Developments PLC
13 June 2024
 

Mast Energy Developments PLC

(Incorporated in England and Wales)

(Registration Number: 12886458)

LEI :213800HFVHGJ9YGO9F71

Share code on the LSE: MAST

ISIN: GB00BMBSCV12

('MED' or 'the Company')

 

Dated: 13 June 2024

 

Mast Energy Developments PLC ('MED' or 'the Company')

 

Business Update

 

Mast Energy Developments PLC, the UK-based multi-asset owner, developer and operator in the rapidly growing flexible power market, is pleased to announce an update regarding business operational matters.

 

Pyebridge

 

Further to the Company's previous announcement dated 21 May 2024, the 2nd Phase work programme regarding the refurbishment of the first of the Pyebridge site's 3x Jenbacher gensets is progressing well and according to plan and expected timeline. The latest status is that the new replacement genset long-block has been received from the supplier in Austria, the existing genset has been disconnected and craned out of the site and transported to Cooper Östlund's workshop. Cooper Östlund has completed the full rebuild of the genset, which involved the replacement of the genset long-block and the replacement and or refurbishment of all the various major and critical engine components onto the new engine block. Following the completion of the rebuild, the refurbished genset was transported back to the Pyebridge site, and successfully craned back into the facility. The final remaining step in the process is the recommissioning of the new genset, which is currently underway. It is expected that the first genset's overhaul work will be fully completed and the genset to start commercial operational running and revenue generation around end of June 2024, in line with the expected timeline.

 

To give more insight into the work-stream involved in overhauling the genset, including photos of key stages during the process, please visit the MED website, "Pyebridge Overhaul Story" webpage at https://med.energy/?page_id=4466.

 

As this process was completed seamlessly within the planned timeline and budget for the first genset, we expect the overhaul of the site's other two gensets to proceed similarly and thus meet our target to have all three gensets overhauled and operating optimally in due course, as previously announced.

 

In the meantime, the Pyebridge site's other two gensets remain operational and will continue to generate revenue via its PPA with Statkraft. Additionally, Pyebridge will also keep receiving its current Capacity Market contract's associated annual gross profit margin income of c. £308,000 from the government, as previously announced.

 

Additionally, as previously announced the Pyebridge site has secured further Capacity Market contracts to ensure minimum annual gross profit margin income as follows:

 

· T-1 2024/2025 CM contract - c. £183,000 gross profit margin income;

· T-4 2026/2027 CM contract - c. £312,000 gross profit margin income; and

· T-4 2027/2028 CM contract - c. £322,000 gross profit margin income.

 

MED expects to bid for and secure an additional T-1 Capacity Market contract for the 2025/2026 delivery year in the next upcoming Capacity Market auction, thereby ensuring uninterrupted minimum guaranteed income until 2028. The Site's existing Capacity Market contracts are all fixed one-year contracts. MED expects to apply for the maximum 15-year term and capacity T-4 Capacity Market contract in due course.

 

The Pyebridge site's Capacity Market contracts' gross profit margin income payments are in addition to its electricity generation trading revenue generation via its PPA with Statkraft. The plan and intention is to add a minimum guaranteed gross profit margin income floor component to its PPA with Statkraft (the "PPA Floor"). The PPA Floor value is currently expected to be at least around £50/kW/annum, subject to certain usual conditions such as assessment and agreement by Statkraft, which would equate to a minimum annual gross profit margin income of £405,000 in addition to the site's Capacity Market contracts' income payments.

 

Both the above referred longer-term Capacity Market contract and the PPA Floor are expected to be implemented once the Pyebridge site's planned overhaul work programme as referred to above has been completed, in order to provide further enhanced and longer term minimum guaranteed gross profit margin income to the site.

 

Pieter Krügel, MED CEO, commented"We are pleased that the overhaul of the first genset at Pyebridge is progressing according to plan, timeline and budget, and near complete. We are looking forward to completing the overhaul work within the expected timeline, and once done, it will increase the Pyebridge site's income generation substantially. The successful completion of the overhaul of the first genset will also establish a proven blueprint to move forward with the overhaul of the site's remaining two gensets, as well as possible application on MED's other sites in due course in order to reduce capex costs.

 

"We are looking forward to updating the market with further progress across the board in due course."

 

ENDS

 

This announcement contains inside information for the purposes of the UK version of the Market Abuse Regulation (EU No. 596/2014) as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018 ('UK MAR'). Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

For further information please visit www.med.energy or contact:

Pieter Krügel

info@med.energy

Mast Energy

Developments PLC

CEO

Jon Belliss

+44 (0)20 7399 9425

Novum Securities

Corporate Broker

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDBLGDLSDBDGSD
Date   Source Headline
19th Oct 20227:00 amRNSPyebridge Trading Update
5th Oct 20227:00 amRNSMED Acquires two Projects and Secures Funding
13th Sep 20222:05 pmRNSSecond Price Monitoring Extn
13th Sep 20222:00 pmRNSPrice Monitoring Extension
23rd Aug 20227:00 amRNSHalf-year Report
8th Aug 20229:46 amRNSTR-1: Notification of major holdings
29th Jul 20222:15 pmRNSPartial Settlement Shareholder Loan & Share Issue
13th Jul 202212:46 pmRNSAppointment of Director
5th Jul 20227:00 amRNSPyebridge Trading and Operational Update
20th May 20227:00 amRNSAppointment of Chief Executive Officer
16th May 202211:24 amRNSResults of Annual General Meeting
20th Apr 20227:00 amRNSNotice of AGM
7th Apr 20227:00 amRNSGeneral Update
31st Mar 20227:00 amRNSResults for the 15 month period ended 31 Dec 2021
24th Feb 20227:00 amRNSBordesley T-4 Capacity Market Auction Results
23rd Feb 20222:05 pmRNSSecond Price Monitoring Extn
23rd Feb 20222:00 pmRNSPrice Monitoring Extension
21st Feb 20229:00 amRNSPrice Monitoring Extension
2nd Dec 20212:36 pmRNSMED Share Issue
15th Nov 20217:00 amRNSPyebridge Steady State Operation and Production
20th Oct 20217:00 amRNSTerm Sheet for Project Development Funding Signed
7th Oct 20217:00 amRNSMED Completes Acquisition of Rochdale Power Ltd
1st Oct 20217:00 amRNSNew Board Appointment
2nd Sep 20217:00 amRNSUnaudited results for the 9 months ended June 2021
16th Aug 20217:00 amRNSMED Acquires Third Standby Generation Facility
12th Aug 202112:48 pmRNSPyebridge Correction of Address Particulars
12th Aug 20217:00 amRNSMED acquires 9 MW Pyebridge Facility
30th Jun 20217:00 amRNSAppointment of Joint Broker
10th Jun 20217:00 amRNSBordesley: Construction to Commence
26th May 20219:05 amRNSHalf-year Report
21st May 20217:00 amRNSBordesley Progresses to Construction-ready Status
6th May 20217:00 amRNSOperational Update
14th Apr 20217:00 amRNSFirst Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.